Sandbox Reserved 966
From Proteopedia
(Difference between revisions)
| Line 16: | Line 16: | ||
== Therapeutic applications == | == Therapeutic applications == | ||
| - | In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum | + | In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. |
| - | First, they try to treat strabismus and in the late 1970s the | + | First, they try to treat strabismus and in the late 1970s the neurotoxin is used in many therapeutic applications. |
=== hyperhidrosis === | === hyperhidrosis === | ||
| + | We can now treat excessive sweating with botulinium toxin thanks to his action on the receptors of the parasympathetic network. Excessive dribbling can be treated in the same way. | ||
=== Cosmetic === | === Cosmetic === | ||
=== Blepharospesm and strabismus === | === Blepharospesm and strabismus === | ||
Revision as of 16:21, 4 January 2015
| This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975. |
To get started:
More help: Help:Editing |
Structure of the "Clostridium botulinum" neurotoxin serotype A light chain with Zn2+ cofactor bound
| |||||||||||
